NDC 0480-3667 – Liraglutide

Liraglutide 6 mg/mL · Injection · Subcutaneous

Human Prescription Drug

Product NDC0480-3667

Product details

Brand name
Liraglutide
Generic name
Liraglutide
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
Injection
Route
Subcutaneous
Marketing category
NDA AUTHORIZED GENERIC · NDA022341
Marketed since
June 24, 2024
Listing expires
December 31, 2027
Pharmacologic class
GLP-1 Receptor Agonist

Active ingredients

Uses, dosage, side effects and warnings for Liraglutide →

Package NDC codes (2)

Package NDCDescriptionSince
0480-3667-202 SYRINGE, PLASTIC in 1 CARTON (0480-3667-20) / 3 mL in 1 SYRINGE, PLASTIC (0480-3667-19)Jun 24, 2024
0480-3667-223 SYRINGE, PLASTIC in 1 CARTON (0480-3667-22) / 3 mL in 1 SYRINGE, PLASTIC (0480-3667-19)Jun 24, 2024

Other Liraglutide products